A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy Meeting Abstract


Authors: Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; King, T.; Berger, M.; Baselga, J.; Rosen, N.; Hudis, C.; Chandarlapaty, S.
Abstract Title: A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
Meeting Title: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 75
Issue: 9 Suppl.
Meeting Dates: 2014 Dec 9-13
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-05-01
Language: English
ACCESSION: WOS:000356730203156
DOI: 10.1158/1538-7445.sabcs14-p5-19-04
PROVIDER: wos
Notes: Meeting Abstract -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos
Altmetric Score
MSK Authors
  1. Sujata Patil
    381 Patil
  2. Clifford Hudis
    837 Hudis
  3. Neal Rosen
    356 Rosen
  4. Diana E Lake
    70 Lake
  5. Harpreet Pannu
    20 Pannu
  6. Tari King
    165 King
  7. Devika Gajria
    23 Gajria
  8. Tiffany A Traina
    153 Traina
  9. Shanu Modi
    132 Modi
  10. Rita Sakr
    59 Sakr
  11. Michael Forman Berger
    380 Berger
  12. Helen Hyeong-Eun Won
    79 Won
  13. Jose T Baselga
    394 Baselga